drugset / Trial / NCT05801575

CHM Teabag Decrease Stroke Risk Among Hong Kong Elderly

NCT05801575 ↗

Unknown 912 enrolled Hong Kong Baptist University
RandomizedParallel-groupSingle-blindPrevention

Summary

This stepped wedge cluster randomized controlled trial aims to examine the efficacy and safety of CHM teabag in decreasing stroke risk by machine-learning-based retinal image analysis in elderly population.

Timeline

Start
2023-02-02
Primary completion
2023-08-30
Completion
2023-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chinese Herbal Medicine (CHM) teabag Traditional medicine (herbal / TCM) 10 g —

Indications